Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats
Background. There are no approved drug treatments for liver fibrosis and nonalcoholic steatohepatitis (NASH), an advanced stage of fibrosis which has rapidly become a major cause of cirrhosis. Therefore, development of anti-inflammatory and antifibrotic therapies is desired. Mesenchymal stem cell- (...
Saved in:
Main Authors: | Masatsugu Ohara (Author), Shunsuke Ohnishi (Author), Hidetaka Hosono (Author), Koji Yamamoto (Author), Kohei Yuyama (Author), Hideki Nakamura (Author), Qingjie Fu (Author), Osamu Maehara (Author), Goki Suda (Author), Naoya Sakamoto (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats
by: Masatsugu Ohara, et al.
Published: (2018) -
Conditioned Medium from Human Amnion-Derived Mesenchymal Stem Cells Regulates Activation of Primary Hepatic Stellate Cells
by: Qingjie Fu, et al.
Published: (2018) -
Oleoylethanolamide Ameliorates Dextran Sulfate Sodium-Induced Colitis in Rats
by: Shinsuke Otagiri, et al.
Published: (2020) -
Computed tomography, not bioelectrical impedance analysis, is the proper method for evaluating changes in skeletal muscle mass in liver disease
by: Masatsugu Ohara, et al.
Published: (2020) -
Extracellular Vesicles Role in Diseases, Pathogenesis and Therapy
Published: (2022)